NY2267
CAS No. 886053-73-2
NY2267( Acetic acid, 2-[[6-[2-(cyclohexylamino)-1-[[(4-methoxyphenyl)methyl](2-pyridinylcarbonyl)amino]-2-oxoethyl]-2-naphthalenyl]oxy]-, 1,1-dimethylethyl ester )
Catalog No. M24905 CAS No. 886053-73-2
NY2267 is a disruptor of Myc-Max interaction, with an IC50 of 36.5 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 222 | In Stock |
|
| 10MG | 357 | In Stock |
|
| 25MG | 597 | In Stock |
|
| 50MG | 851 | In Stock |
|
| 100MG | 1152 | In Stock |
|
| 500MG | 2313 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNY2267
-
NoteResearch use only, not for human use.
-
Brief DescriptionNY2267 is a disruptor of Myc-Max interaction, with an IC50 of 36.5 μM.
-
DescriptionNY2267 is a disruptor of Myc-Max interaction, with an IC50 of 36.5 μM.
-
In Vitro——
-
In Vivo——
-
SynonymsAcetic acid, 2-[[6-[2-(cyclohexylamino)-1-[[(4-methoxyphenyl)methyl](2-pyridinylcarbonyl)amino]-2-oxoethyl]-2-naphthalenyl]oxy]-, 1,1-dimethylethyl ester
-
PathwayCell Cycle/DNA Damage
-
Targetc-Myc
-
Recptorc-Myc-Max
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number886053-73-2
-
Formula Weight637.78
-
Molecular FormulaC38H43N3O6
-
Purity>98% (HPLC)
-
SolubilityDMSO : 250 mg/mL (392.00 mM; Need ultrasonic and warming)
-
SMILESO=C(OC(C)(C)C)COC1=CC=C2C=C(C(N(CC3=CC=C(OC)C=C3)C(C4=NC=CC=C4)=O)C(NC5CCCCC5)=O)C=CC2=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yang Xu,et al. A credit-card library approach for disrupting protein-protein interactions. Bioorg Med Chem. 2006 Apr 15;14(8):2660-73.
molnova catalog
related products
-
10058-F4
10058-F4 is a specific c-Myc inhibitor that disrupts the association between the c-Myc and Max.
-
Nicotinamide-N-oxide
Nicotinamide N - oxide is niacin related compounds, used in the study of nicotinic acid related granulocyte differentiation mechanism.
-
CBL0137
CBL0137 (Curaxin CBL0137) is a histone chaperone FACT (facilitates chromatin transcription) and MYC signal inhibitor that markedly reduced tumor initiation and progression in vivo.
Cart
sales@molnova.com